Torvex
NDC Package 84460-801-01

11-digit billing NDC: 84460080101 · Billing unit: EA · 1 EA per package
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Torvex is diclofenac sodium topical solution is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s). Marketed by Florrax Pharmaceutical, this product is identified by NDC 84460-801.

Identification & Billing

NDC Package Code
84460-801-01
Package Description
1 KIT in 1 CARTON * 1 BOTTLE in 1 CARTON (65162-911-74) / 150 mL in 1 BOTTLE * 85 g in 1 TUBE (51824-105-03)
Product Code
84460-801
11-Digit Billing Format
84460080101
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 311498 - menthol 10 % / methyl salicylate 15 % Topical Cream
  • RxCUI: 311498 - menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream
  • RxCUI: 311498 - menthol 10 GM / methyl salicylate 15 GM per 100 GM Topical Cream
  • RxCUI: 857700 - diclofenac sodium 1.5 % Topical Solution
  • RxCUI: 857700 - diclofenac sodium 15 MG/ML Topical Solution

Clinical Specifications

Proprietary Name
Torvex
Dosage Form
-
Usage Information
Diclofenac sodium topical solution is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s).

Regulatory & Marketing

Labeler Name
Florrax Pharmaceutical
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
03-24-2026
End Marketing Date
09-25-2026
Listing Expiration
09-25-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84460-801-01 identifies a specific commercial package of 1 kit in 1 carton * 1 bottle in 1 carton (65162-911-74) / 150 ml in 1 bottle * 85 g in 1 tube (51824-105-03) of Torvex, labeled by Florrax Pharmaceutical. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Florrax Pharmaceutical on March 24, 2026. The current certification is valid through September 25, 2026.

How is this Florrax Pharmaceutical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84460080101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84460-801-01
11-Digit CMS (5-4-2)
84460-0801-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.